Alumis (ALMS) EBITDA (2023 - 2026)

Alumis (ALMS) posted quarterly EBITDA of -$96.4 million for Q4 2025, up 2.21% year-over-year from -$94.4 million in Q4 2024, and up 16.35% quarter-over-quarter from -$115.3 million in Q3 2025.

Alumis (ALMS) EBITDA (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported EBITDA for 3 consecutive years, with -$96.4 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, EBITDA rose 2.21% year-over-year to -$96.4 million; the TTM figure through Dec 2025 stood at -$453.8 million (down 50.89% YoY), while the FY2025 annual figure was -$453.8 million, down 50.89% from the prior year.
  • EBITDA climbed to -$96.4 million in Q4 2025 per ALMS's latest filing, from -$115.3 million in the prior quarter.
  • Across five years, EBITDA topped out at -$37.6 million in Q2 2023 and bottomed at -$140.5 million in Q2 2025.
  • Historically, EBITDA has averaged -$79.6 million across 3 years, with a median of -$96.4 million in 2025.
  • On a YoY basis, EBITDA climbed as much as 2.21% in 2025 and fell as far as 150.34% in 2025.
  • Alumis' EBITDA stood at -$40.1 million in 2023, then sank by 145.74% to -$98.6 million in 2024, then gained by 2.21% to -$96.4 million in 2025.
  • Business Quant data shows ALMS's EBITDA at -$96.4 million in Q4 2025, -$115.3 million in Q3 2025, and -$140.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 493.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -505.13 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 325.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -2.33 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 133.12 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 231.44 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -1.55 Mn
10 Alumis 3.25 Bn 2.75 Bn - -148.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn